In the new role, Mr. Beyer will take on additional responsibility for leading the company’s commercial businesses, as well as operations, distribution, regulatory affairs, quality assurance and customer excellence, according to an April 24 press release.
He first joined the company in 2014 and was promoted to president of orthopedics in 2020. In 2022, he led Conmed’s acquisition of In2Bones and BioRez.
Prior to joining Conmed, Mr. Beyer spent 21 years in various leadership roles at Stryker.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.